LMS知識社群ePortfolioLogin
1

According to a journal in the New England Journal of Medicine, since the morbidity and complications associated with high-dose chemotherapy are increased it is possible to perform an infusion of autologous hematopoietic stem cells, a form of myeloma supportive management after high-dose therapy.